Mélange d'interférences 3 (pour une utilisation Qualitative

Code: I-025-1ML D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs (+)-propoxyphene; aripiprazole; lacosamide; oxcar...


 En savoir plus

Votre prix
$326.63 1ML
DEMANDER

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs (+)-propoxyphene; aripiprazole; lacosamide; oxcarbazepine; rufinamide; and warfarin. This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory′s analytical methods.

Legal Information

CERILLIANT is a registered trademark of Cerilliant Corporation

application(s)forensics and toxicology
compositionRufinamide, 100 µg/mL, Lacosamide, 100 µg/mL, Warfarin, 1000 µg/mL, (+)-Propoxyphene, 50 µg/mL, Oxcarbazepine, 100 µg/mL, Aripiprazole, 100 µg/mL
concentration50-1000 µg/mL each component in acetonitrile
drug controlestupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)
formliquid
formatmulti-component solution
gradeanalytical standard
manufacturer/tradenameCerilliant®
packagingampule of 1 mL
storage temp.−20°C
technique(s)gas chromatography (GC): suitable, liquid chromatography (LC): suitable
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN
GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.